Detection of infrequent and multiple K-ras mutations in human tumors and tumor-adjacent tissues.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Analytical Biochemistry

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/ABIO.1997.2100PMID 9177704
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.

  1996cited by this paper
• Detection of K-ras mutations in lung carcinomas: relationship to prognosis.

  1996cited by this paper
• Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.

  1996cited by this paper
• High frequency of K‐ras mutations in normal appearing lung tissues and sputum of patients with lung cancer

  1995cited by this paper
• Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis.

  1995cited by this paper
• Alveolar cell hyperplasia in association with adenocarcinoma of lung.

  1995cited by this paper
• c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.

  1994cited by this paper
• Geographic variation of p53 mutational profile in nonmalignant human liver.

  1994cited by this paper
• N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hras1 gene mutations.

  1994cited by this paper
• K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.

  1994cited by this paper
• Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.

  1994cited by this paper
• Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K‐ras‐2 mutation type

  1993cited by this paper
• K‐ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos

  1993cited by this paper
• K‐ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung

  1993cited by this paper
• Oncogenes, suppressor genes, and allele losses in colon cancer.

  1993cited by this paper
• Clinical significance of ras oncogene activation in human lung cancer.

  1992cited by this paper
• Mutational spectrometry: a general approach for hot-spot point mutations in selectable genes.

  1992cited by this paper
• ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.

  1992cited by this paper
• Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.

  1991cited by this paper
• Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.

  1991cited by this paper
• Rapid and sensitive nonradioactive detection of mutant K-ras genes via 'enriched' PCR amplification.

  1991cited by this paper
• Molecular analysis of complex human cell populations: mutational spectra of MNNG and ICR-191.

  1990cited by this paper
• Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.

  1990cited by this paper
• Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.

  1990cited by this paper
• Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

  1989cited by this paper
• Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.

  1989cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes.

  1989cited by this paper
• Fidelity of DNA polymerases in DNA amplification.

  1989cited by this paper
• Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

  1988cited by this paper
• Analysis of RAS oncogene mutations in human lymphoid malignancies.

  1988cited by this paper
• ras genes.

  1987cited by this paper
• DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory.

  1983cited by this paper

• Analysis of Mutations in K-ras and p53 Genes in Sputum and Plasma Samples.

  2020cites this paper
• KRAS and TP53 mutations in bronchoscopy samples from former lung cancer patients

  2017cites this paper
• Detection of point mutations of K-ras oncogene and p53 tumor-suppressor gene in sputum samples.

  2014cites this paper
• PHENOTHIAZINES INDUCE ABORTIVE AUTOPHAGY LEADING TO CANCER CELL DEATH

  2012cites this paper
• Smoking history and lung carcinoma: KRAS mutation is an early hit in lung adenocarcinoma development.

  2012cites this paper
• moking history and lung carcinoma : KRAS mutation is an early hit in lung denocarcinoma development

  2011cites this paper
• KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology.

  2010cites this paper
• New and potential clinical applications of KRAS as a cancer biomarker.

  2010cites this paper
• Sensitive detection of KRAS mutations in archived formalin-fixed paraffin-embedded tissue using mutant-enriched PCR and reverse-hybridization.

  2009cites this paper
• Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non‐small cell lung cancer patients

  2009cites this paper
• Many different tumor types have polyclonal tumor origin: evidence and implications.

  2008cites this paper
• K-ras mutation detection in colorectal cancer using the Pyrosequencing technique.

  2007cites this paper
• High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer

  2006cites this paper
• STUDY OF SPUTUM COLLECTION AND EVALUATION IN THE PITTSBURGH LUNG SCREENING STUDY (PLuSS)

  2006cites this paper
• Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

  2005cites this paper
• Molecular Toxicology Protocols

  2005cites this paper
• Molecular classification and molecular genetics of human lung cancers.

  2004cites this paper
• Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis.

  2004cites this paper
• K-ras mutations in lung carcinomas from nonsmoking women exposed to unvented coal smoke in China.

  2003cites this paper
• Comparison of K-ras gene mutations in tumour and sputum DNA of patients with lung cancer

  2003cites this paper
• Topographic analysis of K-ras mutations in histologically normal lung tissues and tumours of lung cancer patients

  2001cites this paper
• Occupational cancer genetics: infrequent ras oncogenes point mutations in lung cancer samples from chromate workers.

  2001cites this paper
• Prospects for applying genotypic selection of somatic oncomutation to chemical risk assessment.

  2001cites this paper
• Enrichment Methods for Mutation Detection

  2000cites this paper
• K-ras mutations and benign pancreatic disease

  2000cites this paper
• K‐ras gene point mutation in neogenetic lesions of subpleural fibrotic lesions: Either an early genetic event in lung cancer development or a non‐specific genetic change during the inflammatory reparative process

  1999cites this paper
• Lung cancer screening in high-risk populations.

  1999cites this paper
• c-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence

  1999cites this paper
• Characterization of the E‐cadherin–catenin complexes in pancreatic carcinoma cell lines

  1999cites this paper
• Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.

  1999cites this paper
• Validation of the Point-EXACCT method in non-small cell lung carcinomas.

  1998cites this paper
• Microdissection-Based p53 Genotyping: Concepts for Molecular Testing.

  1998cites this paper
• Commonly occurring loss and mutation of the MXI1 gene in prostate cancer

  1998cites this paper
• K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients.

  1997cites this paper
• Identification and analysis of differentially expressed genes in human pulmonary adenocarcinoma

  1997cites this paper